基本信息
文件名称:CDC20-IN-2-生命科学试剂-MCE.pdf
文件大小:460.96 KB
总页数:1 页
更新时间:2025-05-21
总字数:约2.01千字
文档摘要

Hotline:400-820-3792

Inhibitors?ScreeningLibraries?Proteins

www.MedChemE

CDC20-IN-2

Cat.No.:HY-172401

分?式:C??H??Cl?F?N?O?S

分?量:701.26

作?靶点:APC;Apoptosis

作?通路:CellCycle/DNADamage;Apoptosis

储存?式:Pleasestoretheproductundertherecommendedconditionsin

theCertificateofAnalysis.

BIOLOGICALACTIVITY

?物活性CDC20-IN-2(14c)是Cdc20的抑制剂(KD:7.65μM),导致G2/M期阻滞,促进DNA损伤积累,并稳定如

CyclinB1和Bim等关键底物,从?增强凋亡并抑制肿瘤细胞的增殖和迁移。

体外研究CDC20-IN-2(14c)exhibitsIC50valuesof3.28μMand23.86μMinMDA-MB-231andMCF10Acells,

respectively[1].

REFERENCES

[1].XiangyangLe,etal.Design,synthesisandoptimizationofApcinanaloguesasCdc20inhibitorsfortriple-negativebreastcancertherapy.

EurJMedChem.2025May5:289:117434.

McePdfHeight

Caution:Producthasnotbeenfullyvalidatedformedicalapplications.

Forresearchuseonly.

Tel:400-820-3792;021Fax:021E-mail:tech@MedChemE

1/1MasterofBioactiveMolecules—